amlodipine has been researched along with Active Hyperemia in 7 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These findings suggest that the ACE inhibitor imidapril augments RH after 12 weeks of treatment in patients with essential hypertension and that this ACE inhibitor-induced augmentation of RH may be due to an increase in NO." | 7.71 | Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function. ( Higashi, Y; Kajiyama, G; Matsuura, H; Nakagawa, K; Oshima, T; Sasaki, S, 2001) |
| " Forearm blood flow (FBF) was measured in 69 patients with essential hypertension (mild, n = 23; moderate, n = 29; and severe, n = 17 randomly assigned to treatment with either imidapril or amlodipine for 24 weeks in a double-blind fashion during reactive hyperemia and after sublingual administration of nitroglycerin." | 5.10 | Severity of hypertension affects improved resistance artery endothelial function by angiotensin-converting enzyme inhibition. ( Chayama, K; Goto, C; Hara, K; Higashi, Y; Kimura, M; Matsuura, H; Nakagawa, K; Noma, K; Oshima, T; Sasaki, S, 2002) |
| "These findings suggest that the ACE inhibitor imidapril augments RH after 12 weeks of treatment in patients with essential hypertension and that this ACE inhibitor-induced augmentation of RH may be due to an increase in NO." | 3.71 | Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function. ( Higashi, Y; Kajiyama, G; Matsuura, H; Nakagawa, K; Oshima, T; Sasaki, S, 2001) |
| "Hypertension is the major risk factor for SVDs, but how hypertension damages the brain microcirculation is unclear." | 1.62 | Differential restoration of functional hyperemia by antihypertensive drug classes in hypertension-related cerebral small vessel disease. ( Dabertrand, F; Ferris, HR; Greenstein, AS; Harraz, OF; Hill-Eubanks, DC; Koide, M; Longden, TA; Nelson, MT; Wellman, GC, 2021) |
| "Forearm vasodilatory response to reactive hyperemia was improved by temocapril (102 +/- 20% to 168 +/- 25%, P < ." | 1.30 | Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension. ( Hata, T; Higaki, J; Iwatsubo, H; Kumamoto, K; Morita, R; Nagano, M; Ogihara, T; Sakai, T, 1997) |
| " The chronic administration of benazepril (5-10 mg/d) for 20 weeks improved insulin sensitivity, endothelial function (6." | 1.30 | Relationship between endothelial function and fibrinolysis in early hypertension. ( Doba, N; Kimura, Y; Kinouchi, T; Kushiro, T; Mitsuhashi, H; Tomiyama, H; Yoshida, H, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Koide, M | 1 |
| Harraz, OF | 1 |
| Dabertrand, F | 1 |
| Longden, TA | 1 |
| Ferris, HR | 1 |
| Wellman, GC | 1 |
| Hill-Eubanks, DC | 1 |
| Greenstein, AS | 1 |
| Nelson, MT | 1 |
| Felmeden, DC | 1 |
| Blann, AD | 1 |
| Spencer, CG | 1 |
| Beevers, DG | 1 |
| Lip, GY | 1 |
| Okuro, M | 1 |
| Morimoto, S | 1 |
| Takahashi, T | 1 |
| Okaishi, K | 1 |
| Nakahashi, T | 1 |
| Murai, H | 1 |
| Iwai, K | 1 |
| Kanda, T | 1 |
| Matsumoto, M | 1 |
| Iwatsubo, H | 1 |
| Nagano, M | 1 |
| Sakai, T | 1 |
| Kumamoto, K | 1 |
| Morita, R | 1 |
| Higaki, J | 1 |
| Ogihara, T | 1 |
| Hata, T | 1 |
| Tomiyama, H | 1 |
| Kimura, Y | 1 |
| Mitsuhashi, H | 1 |
| Kinouchi, T | 1 |
| Yoshida, H | 1 |
| Kushiro, T | 1 |
| Doba, N | 1 |
| Higashi, Y | 2 |
| Sasaki, S | 3 |
| Nakagawa, K | 2 |
| Matsuura, H | 2 |
| Kajiyama, G | 1 |
| Oshima, T | 2 |
| Kimura, M | 1 |
| Noma, K | 1 |
| Hara, K | 1 |
| Goto, C | 1 |
| Chayama, K | 1 |
3 trials available for amlodipine and Active Hyperemia
| Article | Year |
|---|---|
A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes T
Topics: Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Brachial Artery; Card | 2003 |
Angiotensin I-converting enzyme inhibitor improves reactive hyperemia in elderly hypertensives with arteriosclerosis obliterans.
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis Obli | 2006 |
Severity of hypertension affects improved resistance artery endothelial function by angiotensin-converting enzyme inhibition.
Topics: Adult; Amlodipine; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive | 2002 |
4 other studies available for amlodipine and Active Hyperemia
| Article | Year |
|---|---|
Differential restoration of functional hyperemia by antihypertensive drug classes in hypertension-related cerebral small vessel disease.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Cerebral Smal | 2021 |
Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension.
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calci | 1997 |
Relationship between endothelial function and fibrinolysis in early hypertension.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Brachial | 1998 |
Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Endothelium, Vascular; Female; Forearm; | 2001 |